Informationen:
Fehler:
ID
34166
Beschreibung
Feasibility Study of Stereotactic Body Radiotherapy for Early Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02065960
Link
https://clinicaltrials.gov/show/NCT02065960
Stichworte
Versionen (1)
- 14.01.19 14.01.19 -
Rechteinhaber
see on clinicaltrials.gov
Hochgeladen am
14. Januar 2019
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Breast Neoplasm NCT02065960
Eligibility Breast Neoplasm NCT02065960
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Breast Neoplasm NCT02065960
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
ID.1
Item
women age ≥ 70 years;
boolean
ID.2
Item
new histological diagnosis of invasive carcinoma of the breast, grade i or ii, estrogen and progesterone receptor (er and pr) positive, her2 negative on needle biopsy and limited to stage i (t1 n0 m0) on clinical and radiological assessment with mri of the breasts and axillary ultrasound;
boolean
ID.3
Item
candidate for breast conserving surgery;
boolean
ID.4
Item
signed study consent form completed prior to study entry.
boolean
ID.5
Item
breast cancer with disease within 5 mm from skin or chest wall;
boolean
ID.6
Item
previous or concomitant invasive malignancies treated within 5 years of study entry;
boolean
ID.7
Item
serious non-malignant disease (cardiovascular, pulmonary, systemic lupus or scleroderma), which would preclude to definitive radiation therapy;
boolean
ID.8
Item
psychiatric disorders, which would preclude from obtaining informed consent
boolean
ID.9
Item
geographic inaccessibility for follow-up
boolean